Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Constitutive activation of NRF2, mainly via loss-of-function mutations in the CUL3-adapter KEAP1 or gain-of-function mutations in NFE2L2 , is thought to provide a fitness advantage to tumor cells in confronting metabolic/oxidative stress resulting from dysregulated growth (DeNicola et al, 2011
Bias in plant gene content following different sorts of duplication: tandem, whole-genome, segmental, or by transposition
Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist that showed up to 24.2% weight loss in phase 2 trials at 48 weeks, potentially exceeding both CagriSema and tirzepatide
This framework is valuable for identifying precisely where the antitumor immune response succeeds or fails